Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABAT | P80404 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15158296 | 0.80 | CCR2 (0.38) | — | |
| SCHEMBL12836372 | 0.78 | TSHR (0.40) | ABATLMNATSHRAKR1C3AKR1C1 | |
| SCHEMBL24293988 | 0.78 | ABAT (0.32) | ABATLMNATSHR | |
| SCHEMBL24294001 | 0.74 | ABAT (0.34) | ABATLMNATSHRAKR1C3AKR1C1 | |
| SCHEMBL26805791 | 0.73 | ABAT (0.33) | ABAT | |
| SCHEMBL24294215 | 0.73 | APLNR (0.32) | ABATLMNATSHRAPLNR | |
| SCHEMBL24294266 | 0.69 | GABRP (0.32) | ABAT | |
| SCHEMBL961594 | 0.68 | CCR2 (0.34) | LMNATSHR | |
| SCHEMBL7199959 | 0.67 | ALDH1A1 (0.33) | LMNA | |
| SCHEMBL1242465 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230373895-A1 | ISOMERIZATION OF CYCLOHEXENEDICARBOXYLIC ACID AND ITS DERIVATIVES | UNITED STATES DEPARTMENT OF ENERGY | 2023-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373895-A1 | ISOMERIZATION OF CYCLOHEXENEDICARBOXYLIC ACID AND ITS DERIVATIVES | CYP17A1, CYP21A2, CYP19A1 | ABAT 1172/4885LMNA 238/4885TSHR 3051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.